MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 72 filers reported holding MARKER THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $45 | -99.8% | 169,320 | +83.8% | 0.00% | – |
Q2 2022 | $30,000 | -70.6% | 92,142 | -60.4% | 0.00% | – |
Q1 2022 | $102,000 | -83.8% | 232,478 | -64.8% | 0.00% | – |
Q4 2021 | $628,000 | -48.4% | 661,228 | -8.3% | 0.00% | -100.0% |
Q3 2021 | $1,218,000 | -68.0% | 720,916 | -47.2% | 0.00% | -50.0% |
Q2 2021 | $3,807,000 | +667.5% | 1,364,632 | +515.8% | 0.00% | – |
Q1 2021 | $496,000 | +1553.3% | 221,602 | +988.4% | 0.00% | – |
Q4 2020 | $30,000 | -87.5% | 20,361 | -56.8% | 0.00% | – |
Q3 2019 | $240,000 | -79.5% | 47,093 | -73.5% | 0.00% | -100.0% |
Q1 2019 | $1,172,000 | – | 177,579 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |